evocatal and EUCODIS Bioscience Enter Into Collaboration Agreement
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
Industrial biotech companies EUCODIS Bioscience and evocatal have announced the formation of an alliance to jointly market the companies’ industrial enzyme products, including alcohol dehydrogenases, lipases, and other enzymes.
The two companies will leverage their knowledge of customers’ needs in their respective markets as well as their complementary resources to provide existing and future customers with a broader choice of novel enzymes and related services.
Both parties have already started to align their marketing and sales activities, including their product catalogs, and are representing and marketing each partner’s products at industry trade fairs, beginning with CPhI 2010, Paris, and Biotechnica 2010, Hannover.
Financial terms of the agreement are not being disclosed.
“We are excited about the potential of our alliance with evocatal, who combine an impressive entrepreneurial spirit with a deep understanding of developing innovative enzymes for the fine chemicals industry”, said Thomas Fischer, CEO, EUCODIS Bioscience.
Dr. Thorsten Eggert, CEO of evocatal, agreed: “We also see Eucodis as a strong, technology-driven company with a solid portfolio of branded products. By forming this partnership we truly join our forces allowing the partners to significantly broaden their offerings to existing and to new customers”.
Dr. Michael Puls, CMO of evocatal, commented on the alliance: “We really team up in this process to significantly increase our customers’ benefit. Customers have now access to a larger enzyme portfolio through a single channel and also to a much broader service network.”
“We can thus provide more expertise in biocatalysis,” added Dr. Bhupinder Hundle, Senior VP Marketing and Sales, EUCODIS Bioscience. “This supports both of us in our continuous striving to provide the best possible service.”
The two companies will leverage their knowledge of customers’ needs in their respective markets as well as their complementary resources to provide existing and future customers with a broader choice of novel enzymes and related services.
Both parties have already started to align their marketing and sales activities, including their product catalogs, and are representing and marketing each partner’s products at industry trade fairs, beginning with CPhI 2010, Paris, and Biotechnica 2010, Hannover.
Financial terms of the agreement are not being disclosed.
“We are excited about the potential of our alliance with evocatal, who combine an impressive entrepreneurial spirit with a deep understanding of developing innovative enzymes for the fine chemicals industry”, said Thomas Fischer, CEO, EUCODIS Bioscience.
Dr. Thorsten Eggert, CEO of evocatal, agreed: “We also see Eucodis as a strong, technology-driven company with a solid portfolio of branded products. By forming this partnership we truly join our forces allowing the partners to significantly broaden their offerings to existing and to new customers”.
Dr. Michael Puls, CMO of evocatal, commented on the alliance: “We really team up in this process to significantly increase our customers’ benefit. Customers have now access to a larger enzyme portfolio through a single channel and also to a much broader service network.”
“We can thus provide more expertise in biocatalysis,” added Dr. Bhupinder Hundle, Senior VP Marketing and Sales, EUCODIS Bioscience. “This supports both of us in our continuous striving to provide the best possible service.”
